JPMorgan reports 3.881M HIMS shares (1.7%)

JPMorgan Chase & Co. filed Amendment No. 1 to a Schedule 13G/A reporting beneficial ownership of 3,881,790 shares of Class A common stock of HIMS & HERS HEALTH, INC., representing 1.7% of the class as reported.

Rhea-AI Filing Summary

JPMorgan Chase & Co. filed Amendment No. 1 to a Schedule 13G/A reporting beneficial ownership of 3,881,790 shares of Class A common stock of HIMS & HERS HEALTH, INC., representing 1.7% of the class as reported.

The filing lists specific voting and dispositive powers: sole power to vote 3,399,965, shared power to vote 13, sole power to dispose 3,879,553, and shared power to dispose 2,145. It identifies subsidiaries including J.P. Morgan Trust Company of Delaware and J.P. Morgan Securities LLC. The form is signed by a JPMorgan vice president on 03/05/2026.

Insights

Institutional Ownership Analyst

Large custodian reports a 1.7% stake in HIMS, showing voting and dispositive breakdowns.

JPMorgan Chase reports beneficial ownership of 3,881,790 shares and discloses both voting and dispositive powers, with 3,399,965 shares subject to sole voting power and 3,879,553 shares subject to sole dispositive power. The filing names multiple affiliated entities that hold or control the position.

The filing is an Amendment No. 1 to a Schedule 13G/A, indicating a passive institutional reporting posture under the securities rules; timing and trading intent are not stated in the excerpt.

Corporate Governance Specialist

The report clarifies beneficial control lines among JPMorgan affiliates, useful for shareholder voting analysis.

The schedule itemizes who holds voting versus dispositive authority, which matters when mapping which JPMorgan entities may exercise voting rights at shareholder meetings. Subsidiaries named include J.P. Morgan Trust Company of Delaware and J.P. Morgan Securities LLC.

Any governance impact depends on whether these shares are voted; the filing itself does not state voting intentions or arrangements.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake did JPMorgan report in HIMS (HIMS)?

JPMorgan reported beneficial ownership of 3,881,790 shares, equal to 1.7% of HIMS Class A common stock. The filing is Amendment No. 1 to a Schedule 13G/A and lists the detailed voting and dispositive power breakdowns.

Who at JPMorgan holds voting or dispositive power over the HIMS shares?

The filing shows sole voting power for 3,399,965 shares and sole dispositive power for 3,879,553 shares. It also reports small shared voting and dispositive holdings of 13 and 2,145 shares respectively.

Which JPMorgan affiliates are named in the HIMS ownership filing?

Named affiliates include J.P. Morgan Trust Company of Delaware, J.P. Morgan Securities LLC, JPMorgan Chase Bank, N.A., J.P. Morgan Investment Management Inc., and 55I, LLC as listed in the schedule.

Does the Schedule 13G/A state JPMorgan's intent to vote or sell HIMS shares?

The filing lists voting and dispositive powers but does not state any explicit intent to vote or sell. It is an amendment to a passive Schedule 13G/A and does not disclose trading intentions in the excerpt.

When was the JPMorgan Schedule 13G/A amendment signed?

The schedule is signed by Rachel Tsvaygoft, Vice President, on 03/05/2026. The header also references 02/27/2026 within the filing content.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/05/2026 - 11:49 AM EST Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

HIMS & HERS HEALTH, INC.

(Name of Issuer)

Class A common stock, $0.0001 par value per share

(Title of Class of Securities)

02/27/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP Number(s):

1

Names of Reporting Persons

JPMORGAN CHASE & CO.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,399,965.00
6	Shared Voting Power 13.00
7	Sole Dispositive Power 3,879,553.00
8	Shared Dispositive Power 2,145.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,881,790.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

1.7 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: HIMS & HERS HEALTH, INC.
(b)	Address of issuer's principal executive offices: 2269 Chestnut Street #523 San Francisco CA 94123
Item 2.
(a)	Name of person filing: JPMORGAN CHASE & CO.
(b)	Address or principal business office or, if none, residence: 270 Park Avenue,,New York, NY 10017
(c)	Citizenship: DE
(d)	Title of class of securities: Class A common stock, $0.0001 par value per share
(e)	CUSIP No.: 433000106
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 3881790
(b)	Percent of class: 1.7 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 3399965
	(ii) Shared power to vote or to direct the vote: 13
	(iii) Sole power to dispose or to direct the disposition of: 3879553
	(iv) Shared power to dispose or to direct the disposition of: 2145
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. J.P. Morgan Trust Company of Delaware; J.P. Morgan Securities LLC; JPMorgan Chase Bank, National Association; J.P. Morgan Investment Management Inc.; 55I, LLC
Item 8.	Identification and Classification of Members of the Group.
	If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group. Not Applicable
Item 9.	Notice of Dissolution of Group.
	Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5. Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

JPMORGAN CHASE & CO.

Signature:	Rachel Tsvaygoft
Name/Title:	Vice President
Date:	03/05/2026